-
Is the AIDS Terminator Coming? Gilead's new HIV prevention drug clinical data disclosure shows an effective rate of nearly 100%, requiring only 2 doses per year
On September 12 local time, the results disclosed by GILD. NASDAQ showed that Lenacapavir, a new drug for pre exposure prevention of AIDS virus (HIV) (PrEP), showed high effectiveness again. Among th ...